<!doctype html><html><head><meta charset=utf-8><title>20000 IU vitamin D and MS – less fatigue and relapse</title>
<link rel=stylesheet href="/css/main.css?v=1750249976"><link rel=stylesheet href="/css/pagination.css?v=1750249976"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1750249976"></script><script src="/js/search.js?v=1750249976"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>20000 IU vitamin D and MS – less fatigue and relapse</h1><time>December 17, 2010</time><h1 id=safety-and-t-cell-modulating-effects-of-high-dose-vitamin-d3-supplementation-in-multiple-sclerosis>Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis</h1><p>PLoS ONE 5(12): e15235. doi:10.1371/journal.pone.0015235, Clinicaltrials.gov NCT00940719</p><p>Joost Smolders1,2,3*, Evelyn Peelen1,2,3, Mariëlle Thewissen2, Jan Willem Cohen Tervaert1,2,5, Paul Menheere4, Raymond Hupperts1,3, Jan Damoiseaux2,5</p><p>1 School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands,</p><p>2 Division of Clinical and Experimental Immunology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands,</p><p>3 Academic MS Center Limburg, Orbis Medical Center, Sittard, The Netherlands,</p><p>4 Department of Clinical Chemistry, Maastricht University Medical Center, Maastricht, The Netherlands,</p><p>5 Laboratory for Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands</p><p><a href=mailto:j.smolders@mumc.nl>j.smolders@mumc.nl</a></p><p>Background</p><p>A poor vitamin D status has been associated with a high disease activity of multiple sclerosis (MS). Recently, we described associations between vitamin D status and peripheral T cell characteristics in relapsing remitting MS (RRMS) patients. In the present study, we studied the effects of high dose vitamin D3 supplementation on safety and T cell related outcome measures.</p><p>Methodology/Principal Findings</p><p>Fifteen RRMS patients were supplemented with <strong>20 000 IU/d vitamin D3 for 12 weeks</strong> . Vitamin D and calcium metabolism were carefully monitored, and T cell characteristics were studied by flowcytometry. All patients finished the protocol without side-effects, hypercalcaemia, or hypercalciuria. The median vitamin D status increased from 50 nmol/L (31–175) at week 0 to 380 nmol/L (151–535) at week 12 (P&lt;0.001). During the study, 1 patient experienced an exacerbation of MS and was censored from the T cell analysis. The proportions of (naïve and memory) CD4+ Tregs remained unaffected. Although Treg suppressive function improved in several subjects, this effect was not significant in the total cohort (P = 0.143). An increased proportion of IL-10+ CD4+ T cells was found after supplementation (P = 0.021). Additionally, a decrease of the ratio between IFN-?+ and IL-4+ CD4+ T cells was observed (P = 0.035).</p><p>Conclusion/Significance</p><p>Twelve week supplementation of high dose vitamin D3 in RRMS patients was well tolerated and did not induce decompensation of calcium metabolism. The skewing towards an anti-inflammatory cytokine profile supports the evidence on vitamin D as an immune-modulator, and may be used as outcome measure for upcoming randomized placebo-controlled trials.</p><p>Trial Registration Clinicaltrials.gov NCT00940719</p><p>– – – – – – –</p><h2 id=spantiki-download_filephpfileid1624span><span>[tiki-download_file.php?fileId=1624]</span></h2><h2 id=no-apparent-problems-with-152-ngml-group-average-with-one-individual-having-214-ngml>No apparent problems with 152 ng/ml group average, with one individual having 214 ng/ml</h2><h1 id=pdf-shows>PDF Shows</h1><ul><li><p>More than half had decreased fatigue with vitamin D</p></li><li><p>Relapse rate with vitamin D was only 0.27 per year vs previous 0.80 per year without vitamin D (that they know of)</p></li></ul><h1 id=see-also-vitamindwiki>See also VitaminDWiki</h1><ul><li><p><a href=/posts/overview-of-ms-and-vitamin-d style=color:red;text-decoration:underline title="This link has an unknown page_id: 691">Overview of MS and Vitamin D</a></p></li><li><p><a href=/posts/10000-iu-vitamin-d-plus-1200-mg-calcium-ms-trial style=color:red;text-decoration:underline title="This link has an unknown page_id: 176">10,000 IU vitamin D plus 1200 mg Calcium MS trial April 2010</a> - investigate if get too much Calcium, noticed that it reduced MS relapses</p></li><li><p><a href="https://www.VitaminDWiki.com/tiki-browse_categories.php?parentId=18&amp;sort_mode=created_desc">All items in MS and Vitamin D</a> has 119 items Feb 2012</p></li><li><p><a href=/posts/300000-iu-vitamin-d-monthly-may-treat-ms>300,000 IU vitamin D monthly may treat MS – May 2011</a> injection averaged to 10,000 IU daily</p></li></ul></article></div></div><script src="/js/lightspa.js?v=1750249976"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1750249976",indexUrl:"/search/search_index.json.gz?v=1750249976"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1750249976"></script><script src="/js/tiki-redirects.js?v=1750249976"></script></body></html>